Medicine guide

Revolade 12

As listed in the register: Revolade 12,5 mg, Filmtabletten

12,5 mg ·

  • Prescription only
  • Blood, clotting and anaemia
Active substance
Eltrombopagum
Made by
Novartis Pharma Schweiz AG

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Zur Behandlung von erwachsenen Patienten mit (idiopathischen) immunthrombozytopenischen Purpura (ITP), die auf andere Therapieoptionen (z.B. Kortikosteroide, Immunglobuline oder Splenektomie) nicht genügend ansprachen, bei erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

BulgariaNo exact match for this strength and form

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byNovartis Pharma Schweiz AG
Active substanceEltrombopagum
Used inBlood, clotting and anaemia
Strength12,5 mg
ClassificationB02BX05 · Blood, clotting and anaemia
Dispensing (as stated by the register)Abgabekategorie A
Name in the registerRevolade 12,5 mg, Filmtabletten
Packs14 Tablette(n)
Zulassungsnummer60122
Dosisstärke5

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.